Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

AI lung nodules detection in contextflow and Lung-RADS in mint Lesion

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule detection and segmentation, contextflow highlights findings directly within the mint Lesion platform, where users can seamlessly review, customize or add findings.

mint Lesion supports the Lung-RADS 2022 guidelines, featuring built-in automated scoring to enhance accuracy and consistency in lung nodule evaluation. For high-risk patients, contextflow ADVANCE Chest CT extends its capabilities beyond nodules, assisting in the analysis of COPD and *coming soon* identifying calcifications in coronary vessels, equipping users with deeper insights for comprehensive care.

Explore how the innovative solution is going to be integrated into the cutting-edge deepcOS® AIR® ecosystem. Check out this brief video on Youtube to see it in action.

 

Related Resources

Related Resources

How to improve reading procedures and reduce errors in clinical trials with imaging endpoints

Dr. Laura Oleaga from Hospital Clinìc de Barcelona explains how she and her team have benefitted from implementing mint Lesion™ in the face of an…

LMU University Hospital Munich: Real-time Data Visualization and Analysis in Clinical Ttrials with Imaging Endpoints

“mint Analytics expands your means of structured response assessment in mint Lesion™ by instantaneous visualization of the collected data, as a whole…

Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints

Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials…